Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

NCT06333509 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Primary Plasma Cell Leukemia

Interventions

BIOLOGICAL: CT071

Sponsor

CARsgen Therapeutics Co., Ltd.